NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	influenza prevention
Date of first enrollment	24/3/2014
Target sample size	55
Countries of recruitment
Study type	INTERVENTIONAL
Intervention(s)	Intervention name : BK-FLU Dosage And administration of the intervention : Subcutaneously administer 0.5 mL of BK-FLU twice with interval of 1-4 weeks between administrations. Control intervention name : null

Outcome(s)

Primary Outcome	Safety
Secondary Outcome	Immunogenicity

Key inclusion & exclusion criteria

Age minimum	20
Age maximum	64
Gender	BOTH
Include criteria	healthy Japanese adult
Exclude criteria	Subjects with history of influenza within 6 months Subjects with history of influenza vaccination within 6 months